Maria Andreia Hawkins

Has grant

University College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Medical Imaging Medical Imaging professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Exploring novel solutions of radiotherapy delivery and using biology, imaging, new fractionations and radiobiological models to improve TCP/NTCP ratio

Open Date: 2017-03-31

Close Date: 2022-03-30

Grant: Close

CRUKD/15/011 CHARIOt: A Phase I trial of ATR inhibitor VX970 and radiotherapy in oesophageal cancer

Open Date: 2016-03-01

Close Date: 2020-02-29

Grant: Close

CRUK/14/029: Addition of stereotactic radiotherapy to systemic chemotherapy in locally advanced biliary tract cancers (ABC-07)

Open Date: 2015-01-01

Close Date: 2017-12-31

Grant: Close

CRUK/14/028: SPARC: A Phase I trial of pre-operative, margin intensive, stereotactic body radiation therapy for previously untreated borderline resectable pancreatic cancer

Open Date: 2014-11-01

Close Date: 2018-02-28

Grant: Close

Exploring novel solutions of radiotherapy delivery and using biological imaging, new fractionations and radiobiological models to improve TCP/NTCP ratio

Open Date: 2012-03-31

Close Date: 2017-03-30

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (15)

Charles Mayo

University of Michigan

UNITED STATES

Maria Andreia Hawkins

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (19)

United Kingdom and Ireland Oesophagogastric Cancer Group Cancer Update 2024

Radiotherapy Quality Assurance in the SCOPE2 Trial: What Lessons can be Learned for the Next UK Trial in Oesophageal Cancer?

Reirradiation clinical practice in gastrointestinal abdominal malignancies: an international reirradiation collaborative group (ReCOG) systematic review

A qualitative study exploring participants’ experiences of the SCOPE2 trial: chemoradiotherapy dose escalation in oesophageal cancer

The Impact of National Radiotherapy Guidelines: The UK Anal Cancer Story

ImmunoChemoradiation for Non-Small Cell Lung Cancer: A Meta-Analysis of Factors Influencing Survival Benefit in Combination Trials

The experiences of patients with oesophageal cancer receiving chemoradiotherapy treatment: a qualitative study embedded in the SCOPE2 trial

United Kingdom and Ireland Oesophagogastric Cancer Group Cancer Update 2023

International consensus to define outcomes for trials of chemoradiotherapy for anal cancer (CORMAC-2): defining the outcomes from the CORMAC core outcome set

Differential Response of Pelvic Bone Marrow FDG Uptake in Patients Receiving Concurrent Chemoradiotherapy

Dose-Response Analysis Describes Particularly Rapid Repopulation of Non-Small Cell Lung Cancer during Concurrent Chemoradiotherapy

A Phase II trial of Higher RadiOtherapy Dose In The Eradication of early rectal cancer (APHRODITE): protocol for a multicentre, open-label randomised controlled trial

Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe

Quantitative Analysis of Radiation-Associated Parenchymal Lung Change

Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial

Associations between cardiac irradiation and survival in patients with non-small cell lung cancer: Validation and new discoveries in an independent dataset

A decision tool for radiographer-led abdominal image-guided stereotactic ablative body radiotherapy – Experience from a single institution

SPARC, a phase-I trial of pre‐operative, margin intensified, stereotactic body radiation therapy for pancreatic cancer

NRF2 metagene signature is a novel prognostic biomarker in colorectal cancer

Collaborators (15)

Charles Mayo

Huei-Tyng Huang

Douglas Brand

Chieh-Hsi Wu

Lisette Nixon

Richard Adams

Christopher Peters

Geoff Higgins

THEODORE S. LAWRENCE

Chris Hurt

Catarina Veiga

Alexandra Gilbert

Mark Baxter

David Sebag-Montefiore

Sarah Gulliford

Make your next move.